Citius Oncology logo
Citius Oncology
CTOR | NASDAQ
Chart Builder DCF Calculator
$0.54
-$0.03 (-5.89%)
At close: Nov 16, 2026, 4:00 PM ET
$0.54
-$0.01 (-0.93%)
After-hours: Nov 16, 2026, 4:10 PM ET

Citius Oncology Company Profile

Company profile explained

Company Profile

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.

Key Executives

Name Position
Leonard L. Mazur Chief Executive Officer, President & Executive Chairman
Jaime Bartushak Chief Financial Officer & Treasurer
Myron S. Czuczman Executive Vice President & Chief Medical Officer
Myron Z. Holubiak Executive Vice Chairman & Secretary

Latest SEC Filings

Date Type Title
Oct 26, 2026 8-K Current Report
Oct 23, 2026 8-K Current Report
Jun 01, 2026 424B3 Filing
Jun 01, 2026 8-K Current Report
May 29, 2026 DEF 14C Filing
May 29, 2026 S-3 Filing
May 22, 2026 424B3 Filing
May 19, 2026 PRE 14C Filing
May 15, 2026 8-K Current Report
May 15, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Citius Oncology
Citius Oncology logo
Country United States
IPO Date Dec 8, 2022
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 285
CEO Leonard L. Mazur

Contact Details

11 Commerce Drive Cranford, New York 07016 United States

Stock Details

Ticker Symbol CTOR
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001851484
CUSIP Number 17331Y109
ISIN Number US17331Y1091
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.